Together, these findings suggest that ATP6AP2 plays a pivotal role in cellular pH regulation during therapy-induced senescence, and that altered pH homeostasis appears to be closely associated with immune profile changes in senescent cancer cells. This evidence concerns the gene ATP6AP2 and cancer.